Mutations in MECP2 cause the neurodevelopmental disorder Rett syndrome (RTT). The RTT missense MECP2 R306C mutation prevents MeCP2 from interacting with the NCoR/histone deacetylase 3 (HDAC3) complex; however, the neuronal function of HDAC3 is incompletely understood. We found that neuronal deletion of Hdac3 in mice elicited abnormal locomotor coordination, sociability and cognition. Transcriptional and chromatin profiling revealed that HDAC3 positively regulated a subset of genes and was recruited to active gene promoters via MeCP2. HDAC3-associated promoters were enriched for the FOXO transcription factors, and FOXO acetylation was elevated in Hdac3 knockout (KO) and Mecp2 KO neurons. Human RTT-patient-derived MECP2 R306C neural progenitor cells had deficits in HDAC3 and FOXO recruitment and gene expression. Gene editing of MECP2 R306C cells to generate isogenic controls rescued HDAC3-FOXO-mediated impairments in gene expression. Our data suggest that HDAC3 interaction with MeCP2 positively regulates a subset of neuronal genes through FOXO deacetylation, and disruption of HDAC3 contributes to cognitive and social impairment.
RTT is a neurodevelopmental disorder that leads to impaired motor and intellectual abilities and hand stereotypies, and is often associated with autistic features 1 . Initial studies have indicated that MeCP2 negatively regulates transcription through binding to methylated DNA and recruiting HDAC complexes 2, 3 . However, transcriptional and epigenomic analyses in both mouse brain and human embryonic stem cell (hESC)-derived neurons suggest that MeCP2 may act as a transcriptional activator for a subset of genes [4] [5] [6] [7] [8] . Likewise, emerging evidence indicates that HDACs may regulate dynamic changes in transcription [9] [10] [11] [12] . MeCP2 recruits the Sin3a complex containing HDAC1 and HDAC2, and the NCoR complex with HDAC3 (NCoR/ HDAC3). However, the role of individual HDACs in RTT pathology is unknown, which prompted us to investigate HDAC function in RTT. Recent studies have shown that a cluster of single-amino-acid missense RTT-causative MECP2 mutations abolish the interaction of MeCP2 with NCoR/HDAC3, whereas binding with the Sin3a complex is unaffected 13, 14 . Given that HDAC3 is the major enzymatic component of the NCoR complex, this led us to explore the role of HDAC3 in RTT pathology and whether this could provide clarity for the function of MeCP2 in regulating transcription.
RESULTS

Neuronal loss of HDAC3 leads to abnormal locomotor behavior
To investigate whether loss of HDAC3 models RTT-associated behaviors, and to avoid the embryonic lethality that occurs following deletion of Hdac3 during development 15 , we used Hdac3 conditional knockout (Hdac3 cKO) mice that lack Hdac3 expression in forebrain excitatory neurons. Hdac3 cKO mice were generated by crossing Hdac3 loxP-flanked mice (Hdac3 f/f ) 16 with transgenic Camk2apromoter-driven Cre (CW2) mice 17 . Neuronal loss of HDAC3 was confirmed by immunostaining in the hippocampus ( Supplementary  Fig. 1a-d) and by western blot analysis in the hippocampus and the cortex. HDAC3 expression is maintained in the striatum, as previously described for the CW2-cre line (Supplementary Fig. 1e-j) 17 . To assess locomotor activity, we compared Hdac3 cKO mice with control mice in the open field arena, and found that they exhibited hyperactivity ( Supplementary Fig. 2a-e ) and abnormal exploratory behavior ( Fig. 1a and Supplementary Fig. 2f ). Mecp2 cKO mice generated using the CamKII-Cre93 line lacked MeCP2 in the forebrain, including the striatum, and exhibit modest hypolocomotor activity 18 . Striatal expression of MeCP2 has been shown to regulate locomotor activity 19 . Normal striatal expression of HDAC3 in the CW2-Cre-driven Hdac3 cKO mice ( Supplementary Fig. 1i ,j) suggests that differences in locomotor activity may be a result of regional specificity of the CamKII-Cre lines. Hdac3 cKO mice also displayed impaired motor coordination, as assessed by accelerating rota-rod ( Fig. 1b) , which has been observed in MeCP2 loss-of-function models, including the forebrain-specific Mecp2 cKO mice 18 . In addition to locomotor coordination deficits, Hdac3 cKO mice exhibited hind limb clasping (Fig. 1c) . Stereotypic hand-wringing behavior in RTT patients is thought to resemble hind limb clasping in Mecp2 KO mice 20 . A severe hind limb paralysis was observed a r t I C l e S in neuron-specific Hdac3 cKO mice, supporting our observation of locomotor impairments 15 .
Hdac3 cKO mice exhibit social and cognitive deficits Mice with Mecp2 loss-of-function mutations have been suggested to model RTT, and display impaired sociability and cognition [21] [22] [23] [24] . The sociability of Hdac3 cKO mice was tested using a three-chamber arena, whereby an initial habituation to an empty arena is followed by exposure to an unfamiliar mouse restricted to one of the lateral chambers. Hdac3 cKO mice displayed similar behavior as control mice during the habituation phase (Supplementary Fig. 3a) . Following exposure to an unfamiliar mouse, control mice spent more time in the chamber with the social stimulus ( Fig. 1d) . However, Hdac3 cKO mice spent more time in the non-social chamber, indicating aberrant sociability (Fig. 1d) .
To test whether loss of HDAC3 affects cognition, we assessed object location memory (OLM), a test for hippocampal-dependent episodic memory based on the premise that rodents will preferentially explore a familiar object that moved to a new location. Training of mice to the position of two identical objects, and later repositioning only one object, resulted in control mice spending more time at the novel location ( Fig. 1e) . However, Hdac3 cKO mice spent a comparable amount of time at both the familiar and novel location, indicating a deficit in OLM (Fig. 1e) . The total time spent with both objects was higher for Hdac3 cKO mice ( Supplementary Fig. 3b ), reflecting hyperactivity in these mice and indicating that the sociability deficits of Hdac3 cKO mice were not a result of diminished exploratory behavior.
The Morris water maze (MWM), a spatial learning task, requires mice to locate a hidden platform in an opaque pool of water using visual cues. Despite the hyperactivity of Hdac3 cKO mice, their swim (2, 24) = 11.10, P = 0.0004; Bonferroni post hoc, social versus non-social, P = 0.0441; social versus center, P = 0.0002; n = 9, mice. Hdac3 cKO; one-way ANOVA, F (2,24) = 21.65, P < 0.0001; Bonferroni post hoc, social versus non-social, P = 0.0065; social versus center, P = 0.0058; n = 9 mice. (e) Control and Hdac3 cKO mice were assessed for object location memory as the percent time spent with the object in the novel location versus time spent with the object in the familiar location; two-tailed t test; t (26) = 2.374; P = 0.0253; n = 16, 12 mice. (f) The escape latency (s) to reach the hidden platform during the training days of the MWM was scored for control and Hdac3 cKO mice. Two-way ANOVA; genotype, F (1,133) = 23.65, P < 0.0001; day, F (6,133) = 5.624, P < 0.0001, Bonferroni post hoc; day 1, P > 0.99; day 2, P > 0.99; day 3, P = 0.2874; day 4, P > 0.99; day 5, P = 0.7824; day 6, P = 0.0003; day 7, P = 0.0197; n = 10, 11 mice. (g) During the probe trial (day 8), the percent time spent in the target quadrant and the three control quadrants was scored. Control; one-way ANOVA, F (3, 36) = 4.789, P = 0.0066; Bonferroni post hoc; quadrant 1 (Q1) versus target quadrant (T), P = 0.0325; Q2 versus T, P = 0.0037; Q3 versus T, P = 0.0225; n = 10 mice. Hdac3 cKO; one-way ANOVA, F (3, 40) = 0.6259, P = 0.6025; Bonferroni post hoc; Q1 versus T, P > 0.99; Q2 versus T, P > 0.99; Q3 versus T, P > 0.99; n = 11 mice. (h) During the probe trial (day 8), the number of passes through the location where the hidden platform was positioned during the training (days 1-7) was calculated for control and Hdac3 cKO mice; twotailed t test; t (19) = 3.056, P = 0.0065; n = 10, 11 mice. (i) Contextual fear-conditioned memory scored as percent time spent freezing during a 3-min exposure to the context; two-tailed t test; t (20) = 6.719, P < 0.0001; n = 11, 11 mice. (j) Cued fear-conditioned memory scored as percent time spent freezing during a 3-min exposure to the tone presented in a novel context; two-tailed t test; t (20) = 7.959, P < 0.0001; n = 11, 11 mice. Shown are mean value ± s.e.m. (a,f), and median, 25 th and 75 th percentile, and min and max value (b,d,e,g-j). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. a r t I C l e S speed was similar to that of control mice during training days 1-7 ( Supplementary Fig. 3c ), as observed previously for hyperactive mice in swim tasks 25 . Acquisition of spatial learning in control mice was observed as reduced latency to reach the hidden platform by days 6 and 7, which did not occur in Hdac3 cKO mice ( Fig. 1f) . To assess reference memory, we performed a probe trial 24 h after the last training session (day 8), during which the platform was removed. As expected, Hdac3 cKO mice had diminished memory recall, as indicated by reduced time spent in the target quadrant ( Fig. 1g) and a low number of passes through the platform location ( Fig. 1h) .
To further evaluate hippocampal-dependent learning, we used a fear-conditioning procedure, in which we paired an auditory cue with a mild aversive foot shock. Both control and Hdac3 cKO mice displayed a similar aversive reaction to the foot shock ( Supplementary  Fig. 3d ). Contextual memory recall to the conditioning chamber, as measured by freezing behavior, was impaired in Hdac3 cKO mice (mean, 17.16 ± 4.219%) compared with controls (mean, 65.95 ± 5.908%) ( Fig. 1i) . Likewise, cued memory recall to the auditory tone was impaired in Hdac3 cKO mice (mean, 13.62 ± 5.581%) compared with controls (mean, 66.43% ± 3.589%) ( Fig. 1j) . Activity suppression is an alternative indicator of fear used for hyperactive mice 26 , which compares activity during training (before the shock) with activity during testing. Activity suppression is calculated as a ratio; values below 0.5 indicate a fear response, a value of 0.5 indicates no fear, and values above 0.5 may indicate conditioned safety. Activity suppression in control mice revealed a robust fear response during contextual (mean, 0.2899 ± 0.0416) and cued (mean, 0.3131 ± 0.0289) memory recall ( Supplementary Fig. 3e,f) . Similar to freezing behavior, the activity suppression was impaired in the Hdac3 cKO for contextual (mean, 0.4615 ± 0.0117) and cued (mean, 0.5417 ± 0.0346) memory recall ( Supplementary Fig. 3e,f) . Collectively, behaviors observed in Hdac3 cKO mice resemble a number of phenotypes observed in forebrainspecific Mecp2 cKO mice, including hind limb clasping and abnormal motor coordination, sociability and cue-dependent memory 18 .
HDAC3 positively regulates transcription for a subset of genes Transcriptional analysis of MeCP2 loss of function in the mouse brain and hESC-derived neurons suggests that MeCP2 is a dynamic regulator of transcription [5] [6] [7] ; however, gene expression profiling following HDAC3 loss of function in the brain remains to be explored. 
a r t I C l e S
To assess the transcriptional consequence of HDAC3 loss of function, we performed RNA-seq in the CA1 area of the hippocampus, a region enriched for neurons with deletion of Hdac3 in the Hdac3 cKO mice ( Supplementary Fig. 1a,b ). Successful excision of exons 11-14 in Hdac3 cKO mice was demonstrated by reverse transcriptase (RT)-PCR and quantitative (q)RT-PCR analysis, and quantification of exonspecific read number of the Hdac3 gene locus following RNA-seq ( Supplementary Fig. 4a-d) . Subsequent RNA-seq analysis revealed that 303 genes were differentially regulated in Hdac3 cKO mice compared with controls ( Fig. 2a and Supplementary Table 1 ). Of the 303 genes that exhibited differential expression in the Hdac3 cKO mice, 64.03% of the transcripts were found to be downregulated (194 genes downregulated; 109 genes upregulated). Transcriptional profiling following MeCP2 deletion in the mouse brain and hESC-derived neurons 5-7 also revealed that genes are predominantly downregulated. Gene ontology (GO) analysis of HDAC3 dysregulated genes revealed an enrichment of neuron-specific GO groups, including synaptic transmission, neurological system process and transmission of nerve impulse ( Fig. 2b) . Five immediate-early genes (IEGs: Arc, Fos, Nov, Bdnf and Nr4a1) were downregulated in Hdac3 cKO mice, and we validated these findings by qRT-PCR ( Fig. 2a,c) . Additional neuronal genes that were identified as being downregulated in the Hdac3 cKO mice (Arrdc2, Dusp4, Klf10, Tle1 and Adcyap1) were also validated by qRT-PCR ( Fig. 2a,c) . Genes related to synaptic functions were identified by RNA-seq analysis and confirmed by qRT-PCR as being either downregulated (Gabra5, Chrna5 and Doc2b) wild type versus Mecp2 KO: Arrdc2, P = 0.0039; Dusp4, P = 0.0119; Klf10, P = 0.0112; Tle1, P = 0.0003; Bdnf, P = 0.1318; Nr4a1, P = 0.0005; wild type versus IgG: Arrdc2, P < 0.0001; Dusp4, P < 0.0001; Klf10, P < 0.0001; Tle1, P < 0.0001; Bdnf, P = 0.0003; Nr4a1, P < 0.0001; n = 4, 4, 6 mice. (e) ChIP of MeCP2 and IgG followed by qPCR analysis at the promoters of Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 in hippocampal CA1 region of 3-month-old control and Hdac3 cKO mice (percentage input); one-way ANOVA; Arrdc2, F (2, 9) = 12.58, P = 0.0025; Dusp4, F (2,9) = 6.043, P = 0.0217; Klf10, F (2, 9) = 26.48, P = 0.0002; Tle1, F (2, 9) = 2.967, P = 0.1024; Bdnf, F (2,9) = 6.930, P = 0.0151; Nr4a1, F (2, 9) a r t I C l e S or upregulated (Snap25, Nrgn and Ppp1r1b) in the Hdac3 cKO mice ( Fig. 2a,c) . Downregulation of Fos protein in the CA1 pyramidal cell layer and upregulation of Snap25 in the hippocampus of Hdac3 cKO mice were validated by immunostaining and immunoblotting, respectively, confirming the transcriptional dysregulation that we observed in the Hdac3 cKO mice (Fig. 2d,e ).
To ascertain whether there is a functional link in transcriptional regulation by HDAC3 and MeCP2, we compared the differentially regulated genes in the Hdac3 cKO mice with those identified in the hippocampus of Mecp2 KO mice 27 . We found a significant overlap in genes downregulated in the absence of HDAC3 and MeCP2 ( Fig. 2f and Supplementary Table 2 ). A similar comparison of HDAC3 dysregulated genes was performed with transcriptional analysis obtained from hESCderived neurons with TALEN-mediated MECP2 loss of function 7 . We found a significant overlap in dysregulated genes, and these genes were predominantly downregulated in the Hdac3 cKO and human MECP2 loss-of-function neurons ( Fig. 2g and Supplementary Table 3 ). Our transcriptional data suggest that HDAC3, similar to observations for MeCP2, may facilitate transcription of a subset of neuronal genes.
MeCP2 affects HDAC3 binding at promoters of transcribed genes
To examine whether HDAC3 binds to the regulatory regions of transcribed genes genome wide, we performed chromatin immunoprecipitation (ChIP) against HDAC3 in the hippocampus of 3-month-old wild-type mice, followed by next-generation sequencing (ChIP-seq). The DFilter peak-finding algorithm 28 was used to define HDAC3 binding sites and it identified 6,149 regions. Downstream analysis revealed that HDAC3 binding is enriched at the promoter and 5′ UTR of genes, indicative of a general role for HDAC3 in regulating gene expression ( Supplementary Fig. 5a) . A more detailed analysis was performed using ChromHMM software 29 to assess HDAC3 binding in relation to chromatin states as defined by histone modifications in the mouse hippocampus 30 . HDAC3 was found to bind near the transcriptional start site (TSS) of active gene promoters enriched for histone 3 lysine 27 acetylation (H3K27ac) and H3K4 trimethylation (H3K4me3). HDAC3 binding was also present at some active enhancer elements, as distinguished by H3K27ac and H3K4me1 (Supplementary Fig. 5b) . We generated aggregate plots showing the average HDAC3 binding intensity across the promoters of upregulated and downregulated genes in Hdac3 cKO mice to assess a r t I C l e S whether HDAC3 directly modulates these genes. The average HDAC3 binding intensity was enriched at the promoters of both up-and downregulated genes, including the downregulated genes Tle1 and Klf10 (Supplementary Fig. 5c,d) . This data implicates that HDAC3 directly regulates the expression of genes identified as either up-and downregulated in Hdac3 cKO mice. To further test HDAC3 binding at genes downregulated in our RNA-seq, we carried out HDAC3 ChIP in the hippocampus of 3-month-old wild-type mice followed by qPCR analysis for Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1. HDAC3 binding was enriched near the TSS or promoters of all six genes (Supplementary Fig. 5e ). HDAC3 binding was reduced at these gene regulatory regions in hippocampal CA1 of 3-month-old Hdac3 cKO mice relative to controls, indicating the specificity of the HDAC3 antibody (Supplementary Fig. 5f) .
Given that HDAC3 is a binding partner of MeCP2 (ref. 13) , we assessed whether global chromatin distribution of HDAC3 is perturbed in the absence of MeCP2. HDAC3 ChIP-seq was carried out in the hippocampus of Mecp2 KO mice and wild-type littermates at postnatal day 45 (P45), when Mecp2 KO mice exhibit RTT-like phenotypes 20 . HDAC3 binding in P45 wild-type hippocampus was enriched at the TSSs of active gene promoters genome wide (Fig. 3a,b) , and at the TSSs of genes upregulated and downregulated in the Hdac3 cKO ( Fig. 3c) , similar to that of 3-month-old wild-type hippocampus (Supplementary Fig. 5a-c) . In P45 Mecp2 KO hippocampus, HDAC3 binding at active promoters and HDAC3 dysregulated genes was reduced (Fig. 3a-c and Supplementary Fig. 6a) . Given that behavioral and transcriptional effects of Hdac3 cKO mice are similar to those of MeCP2 loss of function, we assessed HDAC3 binding at the promoters of genes dysregulated in the hippocampus of Mecp2 KO mice 27 . HDAC3 binding at the TSSs of genes downregulated and upregulated in the hippocampus of Mecp2 KO mice was enriched in P45 wild-type hippocampus and reduced in the absence of MeCP2 (Supplementary Fig. 6b,c) .
Our ChIP-seq analysis revealed that HDAC3 recruitment to the promoter of active genes was altered in the absence of MeCP2. This was further tested by ChIP qPCR analysis of MeCP2 and HDAC3 binding at the promoter of six genes identified as being downregulated in both Hdac3 cKO mice ( Fig. 2a) and Mecp2 KO neurons 7 . MeCP2 binding was enriched at the gene promoters of Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 in P45 wild-type hippocampus, but was not enriched in Mecp2 KO neurons, indicating that the antibody is specific ( Supplementary Fig. 6d ). Furthermore, we observed decreased HDAC3 binding at these promoters in the absence of MeCP2 (Fig. 3d) , indicating that MeCP2 regulates HDAC3 binding at these genes. Conversely, we tested whether DNA binding of MeCP2 is regulated by HDAC3. MeCP2 was enriched at the gene promoters of Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 in 3-month-old hippocampal CA1 of both control and Hdac3 cKO mice (Fig. 3e) . Our ChIP-seq and qPCR analysis revealed that MeCP2 regulates HDAC3 binding at the promoter region of active genes, including a subset of genes downregulated in Hdac3 cKO mice.
HDAC-containing chromatin complexes are thought to modulate gene expression through deacetylation of histones, which closely correlates with gene repression. To test whether histone acetylation at promoters is altered in the hippocampal CA1 of Hdac3 cKO mice, we assessed acetylation of histone H3 lysine 27 (H3K27ac), H3K9ac and H4K12ac by ChIP qPCR. H3K27ac is enriched at active promoters and enhancers, H3K9ac at the promoters of transcribed genes, and H4K12ac is associated with learning-induced gene expression 31 . Both H3K9ac and H4K12ac have been shown to be elevated following HDAC3 loss of function in mouse embryonic fibroblasts and hepatoctyes 32, 33 .
We found an enrichment of H3K27ac, H3K9ac and H4K12ac at the promoter of Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 (Fig. 3f  and Supplementary Fig. 6e,f) . There was no significant change in H3K27ac, H3K9ac or H4K12ac at these promoters in Hdac3 cKO mice compared with controls ( Fig. 3f and Supplementary  Fig. 6e,f) . Together with our RNA-seq analysis (Fig. 2a) , these data indicate that Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 are actively transcribed genes in the hippocampus and that downregulated expression of these genes in Hdac3 cKO may be independent of histone acetylation.
HDAC3 promotes localization of FOXO3 at active gene promoters
To gain a mechanistic insight into transcriptional regulation by HDAC3 and MeCP2, we assessed enrichment of common conserved putative cis-regulatory elements using the MSigDB motif gene data set. The most enriched known transcription-factor-binding motif identified at genes downregulated in the hippocampus of Hdac3 cKO was the TTGTTT motif for the FOXO transcription factors ( Supplementary  Fig. 7a ). Furthermore, the FOXO motif was highly enriched among genes that were downregulated in the hippocampus, hypothalamus and cerebellum of Mecp2 KO mice 5, 6, 27 (Supplementary Fig. 7a ). We extended our analysis to global HDAC3 binding peaks, as identified by our ChIP-seq data, for enrichment of common de novo motifs using MEME-ChIP software and identified a significant enrichment for a sequence that matched the FOXO binding motif ( Fig. 4a and  Supplementary Fig. 7b) .
The FOXO family members FOXO1 and FOXO3 have been identified as direct targets for deacetylation by HDAC3 in the liver 34 . To test whether HDAC3 and FOXO colocalize at the promoter of transcribed genes, we performed ChIP qPCR in 3-month-old wild-type hippocampus. There are four genes coding for FOXO transcription factors in mouse and human: Foxo1, Foxo3, Foxo4 and Foxo6. Our RNA-seq data revealed Foxo3 had the highest expression in the hippocampal CA1 region (Supplementary Fig. 7c) ; thus, we performed ChIP experiments targeting FOXO3. Both HDAC3 and FOXO3 bound at the same promoter regions of six genes that were downregulated in Hdac3 cKO mice: Arrdc2, Dusp4, Klf10, Tle1, Bdnf and Nr4a1 (Fig. 4b) . Collectively, these data indicate that HDAC3 binding at a subset of genes downregulated in Hdac3 cKO mice is modulated by MeCP2 and that HDAC3 and FOXO3 are colocalized at these same genomic regions.
Acetylation of the FOXO transcription factors has been shown to reduce their binding affinity to DNA and inhibit their ability to activate gene transcription [35] [36] [37] . To determine whether FOXO acetylation is altered in neurons lacking HDAC3, we infected primary neuronal cultures prepared from Hdac3 f/f embryonic cortices with lentivirus expressing Cre recombinase tagged with GFP (Cre-GFP). Immunostaining with an antibody to acetyl-FOXO1 that also detects acetyl-FOXO3 (ref. 34 ) revealed that FOXO acetylation was elevated in Hdac3 KO neurons (Hdac3 f/f ;Cre-GFP) compared with controls (Hdac3 f/f ;GFP) ( Fig. 4c) . Furthermore, levels of acetylated FOXO in 3month-old Hdac3 cKO mice were markedly elevated in CA1 neurons (Fig. 4d) , and were normal in the striatum (Supplementary Fig. 7d) .
These results indicate that in vivo HDAC3 regulates FOXO acetylation in neurons. Acetylated FOXO was also increased in the hippocampus of P45 Mecp2 KO mice compared with controls ( Fig. 4e) .
Next, we tested whether FOXO3 directly binds MeCP2 and HDAC3 using co-immunoprecipitation experiments with recombinant human protein. FOXO3 co-immunoprecipitated HDAC3/NCoR, but not MeCP2 (Supplementary Fig. 7e) , and HDAC3/NCoR was confirmed to co-immunoprecipitate MeCP2 (Supplementary Fig. 7f) 13 . FOXO3 binding to chromatin was then assessed at the promoters of Arrdc2, a r t I C l e S Dusp4, Klf10, Tle1 and Bdnf in hippocampal CA1 of Hdac3 cKO mice by ChIP qPCR, and we found that FOXO3 binding was reduced compared with controls ( Fig. 4f) . Collectively, these data suggest that DNA binding of FOXO may be compromised following the loss of MeCP2 through decreased recruitment of HDAC3 and increased FOXO acetylation.
HDAC3 and FOXO3 function is impaired in human MECP2 R306C cells
To determine whether human RTT-causative mutations of MECP2 affect HDAC3 and FOXO3 binding at gene promoters, we obtained induced pluripotent stem cells (iPSCs) derived from a 7-year-old RTT patient harboring a heterozygous MECP2 R306C point mutation (Coriell: GM23298). The R306C mutation is located in the transcriptional repressor domain of MeCP2, selectively blocking its interaction with NCoR/HDAC3 13, 14 . The MECP2 R306C -derived iPSCs have skewed X-inactivation, and express only the MECP2 R306C allele 38 . Sequencing of genomic (g)DNA from MECP2 R306C iPSCs revealed the heterozygous mutation (Supplementary Fig. 8a) , whereas sequencing of complementary (c)DNA revealed expression of only the MECP2 R306C allele (Supplementary Fig. 8b) . To ensure homogeneity of the MECP2 allele expression, we generated neural progenitor cells (NPCs) from single-cell-derived MECP2 R306C iPSC lines. Sequencing of cDNA derived from two independent MECP2 R306C NPC lines (lines 4 and 14) showed exclusive expression of the MECP2 R306C mutated allele (Supplementary Fig. 8c ). Two independent isogenic control iPSC lines (lines 6 and 36) were generated from the MECP2 R306C iPSCs using CRISPR/Cas9-mediated gene editing to correct the R306C mutation (Supplementary Fig. 8d ). CRISPR/Cas9 editing was successfully designed to target only the mutant allele (Online Methods), as indicated by the inclusion of two heterozygous silent mutations, indicating high specificity of genome editing (Supplementary Fig. 8d ). Five predicted off-target sites were also verified as being unedited by PCR sequencing (Supplementary Fig. 9 ). NPCs were generated from the isogenic control iPSC lines and from iPSCs of a healthy individual (C1; ATCC: CRL-2097) 39 . All NPC lines were validated by immunostaining for the human NPC marker Musashi-1 (MSI1) and Nestin (Supplementary Fig. 7g) .
To test whether the RTT-causative point mutation of MeCP2 affects HDAC3 recruitment to the promoters of genes downregulated in the Hdac3 cKO mice, we performed ChIP qPCR experiments using NPCs from the healthy individual (C1), two MECP2 R306C lines and two isogenic control lines (Fig. 5a) . We found that HDAC3 binding was reduced at the promoters of ARRDC2, KLF10, TLE1, BDNF and NR4A1 in MECP2 R306C NPCs compared with the C1 healthy control and isogenic control NPCs (Fig. 5b) , consistent with reports that the interaction of mutant MeCP2 R306C with NCoR/HDAC3 is compromised 13, 14 .
To test whether FOXO function is altered in the MECP2 R306C NPC lines, we assessed FOXO3 binding at these same promoter regions, as well as FOXO acetylation levels. We found that acetylation of FOXO was elevated in the MECP2 R306C NPC lines compared with the C1 healthy control and isogenic control lines (Fig. 5c, d) . Furthermore, FOXO3 binding was compromised in the MECP2 R306C NPC lines compared with the C1 healthy control and isogenic control NPCs (Fig. 5e) .
These data indicate that the RTT-causative MeCP2 point mutation located outside of the methyl DNA binding domain reduces the recruitment of HDAC3 and FOXO3 to gene promoters. Lastly, gene expression of ARRDC2, KLF10, TLE1 and BDNF was decreased in MECP2 R306C NPCs compared with the C1 healthy control, and was rescued in the isogenic control NPCs to levels that surpassed the C1 healthy control (Fig. 5f) . Together, our data indicate that MeCP2, in concert with HDAC3, can regulate gene transcription through modulating FOXO deacetylation and binding to DNA.
DISCUSSION
We found that neuronal deletion of HDAC3 causes the behavioral phenotypes that are observed in Mecp2 loss-of-function mouse models of RTT, including impaired locomotor coordination, sociability and cognition. The genetic manipulations that we used to examine HDAC3 loss over a prolonged period likely reflect disease conditions; however, previous work suggests that an acute reduction in HDAC3 activity may be beneficial for aspects of cognition 40 . Similar to models of RTT, we found that HDAC3 positively regulates the transcription of a subset of neuronal genes and that MeCP2 regulates global recruitment of HDAC3 to the promoter of active genes. At a subset of gene promoters, loss of HDAC3 impairs recruitment of FOXO3 and correlates with elevated levels of FOXO acetylation, a modification that likely affects its binding to DNA. The lack of changes in histone acetylation at the promoters of downregulated genes in the Hdac3 cKO mice suggests a departure of the conventional role for HDAC3 in regulating histone acetylation, at least for certain genes regulating neuronal functions. Rather, HDAC3 appears to adopt a unique role in regulating acetylation of transcriptional factors in neuronal lineages. Notably, NPCs derived from an RTT patient harboring an MECP2 mutation that prevents MeCP2 interaction with NCoR/HDAC3 13 showed impaired HDAC3 and FOXO3 localization to the promoters of downregulated genes. Collectively, our data support a role for MeCP2 and HDAC3 in regulating transcription factor recruitment and creating an environment permissive for gene expression, which is dysregulated in RTT patient-derived NPCs.
Loss of MeCP2 and HDAC3 also leads to increased expression of a number of genes, which are likely suppressed by this complex. A recent analysis of gene expression data sets from Mecp2 mutant mice, including Mecp2 R306C mice, found that MeCP2 loss of function leads to increased expression of long genes 41 . Specifically, MeCP2mediated repression of long genes correlates with MeCP2 binding to methylated CA sites in the gene body 41, 42 . MeCP2 binds broadly to chromatin in neurons, and its genomic localization likely affects its function as a transcriptional regulator. One possibility is that MeCP2 binding in the body of long genes suppresses transcription, whereas MeCP2 recruitment of HDAC3 to certain gene promoters positively regulates transcription. Whether MeCP2 interacts with the NCoR/ HDAC3 complex in long genes remains to be determined. However, the molecular targets for HDAC3-mediated deacetylation in gene bodies likely differ from those located at promoter regions.
Many transcription factors and chromatin regulators are known to be acetylated 43 ; thus, HDAC3-mediated deacetylation could be applicable to multiple chromatin factors. In this regard, binding motifs for TCF/ LEF, mediators of Wnt signaling, were also enriched among genes downregulated in Hdac3 cKO and Mecp2 KO mice. It would be interesting to test whether Wnt signaling, a pathway that is implicated in the autism spectrum disorders 44 , is regulated by MeCP2 and HDAC3. Network analysis of gene expression and protein interaction profiles implicate the NCoR/HDAC3 complex in autism and intellectual impairment 45 . Human mutations in two key components of the NCoR/HDAC3 complex, TBL1XR1 and TBL1X, are associated with sporadic autism 46, 47 . TBL1XR1 human mutations are also linked to intellectual disability 48 , as well as to a patient diagnosed with West syndrome who displayed RTT-like features 49 . Taken together with our observations that HDAC3 loss leads to social and cognitive impairments, the transcriptional function of NCoR/HDAC3 could be more widely applicable to the autism spectrum disorders and intellectual disability. a r t I C l e S METHODS Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Accession codes. Sequencing data are available from the NCBI Gene Expression Omnibus (GEO) database under accession number GSE72196.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. 5 µg MeCP2 (Sigma, M6818), 1 µg H3K9ac (Abcam, ab4441) 55 , 1 µg H4K12ac (Millipore, 07-595) or normal rabbit IgG (Millipore, 12-370) antibody incubated overnight, followed by enrichment using protein A sepharose beads for 4 h. Beads were washed 4 times with RIPA buffer (50 mM Hepes pH 7.6, 10 mM EDTA, 0.7% sodium deoxycholate, 1% NP-40, 0.5 M LiCl), and once with TE (50 mM Tris HCl, 10 mM EDTA). Chromatin was eluted by agitation at 65 °C for 20 min in TES (TE plus 1% SDS), and reverse crosslinked overnight at 65 °C. Chromatin was subjected to RNase and proteinase K treatment, followed by DNA purification by phenol chloroform extraction and ethanol precipitation. DNA pellets were resuspended in 10 mM Tris and subjected to qPCR or ChIP-seq analysis. mouse primer sequences. Arrdc2_F AAAAGAGATCGGCCAGGTG, Arrdc2_ R CCGCTTGTGTGTGTACGTAG; Dusp4_F AGCCCTCTCTCGTAAAC ACA, Dusp4_R ATAGCAGTCCCAGCCTTCTC; Klf10_F CTCTGTCAGT GGAGCGTGTA, Klf10_R AGGACTGAAGGCTAGGGTTG; Tle1_F CTTCT GCAAACTTCAACCCC, Tle1_R GCCGAGCTGTCAATCAAAGT; Bdnf_F GCGGTGTAGGCTGGAATAGA, Bdnf_R GCGGTGTAGGCTGGAATAGA; Nr4a1_F TCAACGACGATTTGCATGCT, Nr4a1_R GCCAGGATTCCATT ACATCACC.
Human primer sequences. ARRDC2_F CCGAGGATGGCAAAGTCAAC, ARRDC2_R ACTTCCTGGTCCTCTGCATC; KLF10_F GAGCGTGTAC ACAATCCCC, KLF10_R GCGTCACTCAATCAGGTGG; TLE1_F GACGCCA AAACCAGCCAAT, TLE1_R ACTTTGATTGACAGCCCAGC; BDNF_F TTCTTTGCGGCTTACACCAC, BDNF_R CCGGGTTGGTATACTGGGTT; NR4A1_F AACGAATCCAGAGCCTGTGA, NR4A1_R TCTGATAACGAG TCCCAGCC.
library Preparation for RnA-seq and chIP-seq. Libraries were prepared and sequenced as previously described 30 . RNA-seq of the CA1 region of the hippocampus was performed using two replicates for control and Hdac3 cKO samples. RNA-seq reads were aligned to the mouse mm9 genome using TopHat. The mean yield per sample was 34.33 million 36-bp single-end reads, of which 31.17 million reads were aligned (90.8%).
HDAC3 ChIP-seq of the 3-month-old wild-type hippocampus (C57BL/6J), P45 wild-type hippocampus and P45 Mecp2 KO hippocampus was performed using three replicates. For 3-month-old wild-type hippocampus, after filtering, a total of 94 million unique reads (roughly 30 million reads per replicate) were obtained for the HDAC3 ChIP, and 78.8 million reads were obtained for total input. For P45 wild-type hippocampus, after filtering, a total of 10 million unique reads were obtained for the HDAC3 ChIP, and 16 million reads were obtained for total input. For P45 Mecp2 KO hippocampus, after filtering, a total of 13 million unique reads were obtained for the HDAC3 ChIP, and 16 million reads were obtained for total input. Sequencing reads were mapped to the mm9 mouse genome using BWA aligner (samse option). Duplicate reads were marked and removed using SAM tools.
RnA-seq and chIP-seq analysis. For RNA-seq analysis, aligned reads were mapped to the RefSeq database and counted (HTSeq). Differential expression analysis was performed using DESeq (Bioconductor) followed by Student t test to model the experimental and gene-specific dispersion, respectively. Genes were considered differentially expressed if P ≤ 0.05. Ontological analyses of differentially expressed genes were performed using Gene Set Enrichment Analysis (GSEA) for GO biological process (MSigDB, Broad Institute). Transcription factor-binding motif analysis of RNA-seq data was performed using GSEA for transcription factor targets (MSigDB, Broad Institute). To compare differentially expressed genes (DEG) in the Hdac3 cKO with DEG from human-derived MECP2 KO neurons 7 , mouse gene names were converted to human homologs using MGI annotation database (http://www.informatics.jax.org/homology.shtml).
For ChIP-seq analysis, ChIP reads were normalized and presented as a ratio over input reads using dFilter software 28 . Bigwig files and HDAC3 peaks were generated using dFilter software and visualized using the UCSC genome browser. Enrichment of HDAC3 binding peaks over genome (Fig. 3a) was assessed using HOMER software. Enrichment of HDAC3 binding peaks over chromatin states (Fig. 3b) was assessed with ChromHMM software 56 , using chromatin states obtained from the hippocampus of adult mice 30 . Aggregation plots of normalized ChIP-seq intensity were generated using deepTools Galaxy with ComputeMatrix set to 3,500 bp upstream and downstream of the TSS. De novo motif analysis was assessed with MEME-ChIP using nucleotide sequences (FASTA format) identified as HDAC3 binding peaks. Data deposited under accession number GSE72196. For HDAC3 ChIP-Seq data generated from wild-type and Mecp2 KO mice, the raw data were mapped to mouse mm9 reference genome using BWA aligner. After filtering out duplicate reads (PCR artifact), the reads from biological replicates were concatenated for peak calling using dFilter software (threshold P value = 10 −5 , bin size = 25 bp, kernel size = 50 bp). Enrichment of HDAC3 binding peaks at different genomic regions were compared for WT and Mecp2 KO mice.
In vitro FoXo3 binding assay. Human recombinant proteins were purchased: MeCP2 (Abnova, H00004204-P01), HDAC3/NCOR1 (Enzo Life Sciences, BML-SE15-0050) and FOXO3 (OriGene, TP302894). Binding assays were carried out in a final volume of 30 µl in binding buffer (50 mM Tris HCl pH 8.0, 0.1 mM EDTA, 1 mM DTT, 10% glycerol, 1 mM PMSF) containing 1 µg of each recombinant protein. Samples were incubated at 30 °C for 60 min, then supplemented in 80 µl binding buffer and 10 µl (2 µg) FOXO3 H-144 antibody (Santa Cruz, sc-11351) and incubated at room temperature (20 -22 °C) for 60 min. Protein A sepharose beads (30 µl) were added to each sample and rotated at 4 °C for 2 h, followed by five washes (5 min each) in 1 ml binding buffer. Beads were eluted in 2× Laemmli buffer followed by western blot analysis.
Statistics.
Results are presented in dot plots as mean ± s.e.m. or in box-and-whisker plots as median, 25th and 75th percentile, min and max value. All statistical analysis was performed using Prism GraphPad software. Data distribution was presumed to be normal with equal variance between groups, however, this was not formally tested. Comparison data consisting of two groups was analyzed by two-tailed unpaired t tests. Comparison of data consisting of three or more groups was analyzed by one-way ANOVA followed by Bonferroni post hoc test. Comparison of two or more factors across multiple groups was analyzed by twoway ANOVA followed by Bonferroni post hoc test. The statistical test, exact P values, sample size (n), t values, ANOVA F values, and degrees of freedom for each experiment is specified in the figure legend. No statistical method was used to estimate sample size, but is consistent with previous publications. Molecular and biochemical analysis was performed using a minimum of three biological replicates per condition. Behavioral experiments require larger data sets due to increased variability. All behavioral experiments consist of a minimum of nine animals per group.
A Supplementary methods checklist is available.
data availability. Sequencing data are available from the NCBI Gene Expression Omnibus (GEO) database under accession number GSE72196. Additional data that support the findings of this study are available from the corresponding author upon request.
